FTISX
Price
$39.34
Change
-$0.15 (-0.38%)
Updated
Jun 2 closing price
Net Assets
5.61B
PICRX
Price
$44.56
Change
-$0.24 (-0.54%)
Updated
Jun 2 closing price
Net Assets
342.72M
Interact to see
Advertisement

FTISX vs PICRX

Header iconFTISX vs PICRX Comparison
Open Charts FTISX vs PICRXBanner chart's image
FTISX vs PICRX Comparison Chart in %
View a ticker or compare two or three
VS
FTISX vs. PICRX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTISX is a Hold and PICRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTISX has more cash in the bank: 5.61B vs. PICRX (343M). PICRX pays higher dividends than FTISX: PICRX (5.61) vs FTISX (2.73). FTISX was incepted earlier than PICRX: FTISX (23 years) vs PICRX (23 years). PICRX (1.78) is less costly to investors than FTISX (1.45). PICRX is a more actively managed with annual turnover of: 30.00 vs. FTISX (24.00). FTISX (0) and PICRX (0) have matching initial minimum investment requirements. FTISX annual gain was more profitable for investors over the last year : 18.07 vs. PICRX (3.54). FTISX return over 5 years is better than : 25.95 vs. PICRX (7.68).
FTISXPICRXFTISX / PICRX
Total Expense Ratio1.451.7384%
Annual Report Gross Expense Ratio1.451.7881%
Fund Existence23 years23 years-
Gain YTD10.3692.941353%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.61B343M1,636%
Annual Yield % from dividends2.735.6149%
Returns for 1 year18.073.54511%
Returns for 3 years47.6937.26128%
Returns for 5 years25.957.68338%
Returns for 10 years88.5450.36176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OFIX9.720.45
+4.85%
Orthofix Medical
USEG1.080.01
+0.93%
US Energy Corp
BSAAU11.13N/A
N/A
Best Spac I Acquisition Corp
AAL13.93-0.41
-2.86%
American Airlines Group
VRDN15.86-1.10
-6.49%
Viridian Therapeutics